Pyrrole [2,3 -d]pyridadazin -4 -onas and pyrazole [3,4 -d]pyridadazin -4 -onas replaced as protein kinase inhibitors

• 收藏
• 分享

专利权人:

FOCHON PHARMACEUTICALS, LTD.;SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.

发明人:

BIN LIU,HAOHAN TAN,JING SUN,KAI RAN,LIJUN YANG,LING CHEN,MIN LIN,RUI TAN,WEIBO WANG,WEIPENG ZHANG,XIANLONG WANG,XINGDONG ZHAO,ZHIFANG CHEN,ZHIFU LI,ZONGYAO ZOU

申请号：

BR112018076622

公开号：

BR112018076622A2

申请日:

2017.06.20

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

Certain pharmacokinetic compounds or salts that may inhibit the activity of gross tyrosine kinase (btk) are provided and may be useful for the treatment of diseases such as cancer, immunological disease and inflammation.são fornecidos certos compostos ou sais farmaceuticamente aceitáveis do mesmo que podem inibir a atividade cinase de tirosina cinase de bruton (btk) e podem ser úteis para o tratamento de doenças como câncer, doença imunológica e inflamação.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/